Log in to save to my catalogue

A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase

A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_906f7b7b067c4feeb9c81178946ffe5e

A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase

About this item

Full title

A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase

Publisher

Brazil: Associacao Brasileira de Divulgacao Cientifica (ABDC)

Journal title

Brazilian journal of medical and biological research, 2017-01, Vol.50 (4), p.e5727

Language

English

Formats

Publication information

Publisher

Brazil: Associacao Brasileira de Divulgacao Cientifica (ABDC)

More information

Scope and Contents

Contents

Chediak-Higashi syndrome (CHS) is a rare autosomal recessive immunodeficiency disease characterized by frequent infections, hypopigmentation, progressive neurologic deterioration and hemophagocytic lymphohistiocytosis (HLH), known as the accelerated phase. There is little experience in the accelerated phase of CHS treatment worldwide. Here, we pres...

Alternative Titles

Full title

A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_906f7b7b067c4feeb9c81178946ffe5e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_906f7b7b067c4feeb9c81178946ffe5e

Other Identifiers

ISSN

0100-879X,1414-431X

E-ISSN

1414-431X

DOI

10.1590/1414-431x20165727

How to access this item